Client
InnoSign
DELIVERABLES
Branding
Visual identity
Packaging design
Webdesign & development
CHALLENGE
In 2010, Philips embarked on an innovative new product aimed at improving cancer treatment. Not with a new drug, but with OncoSignal, a platform fueled by Artificial Intelligence (AI) enabling next-generation precision medicine with the use of big data. After 12 years, OncoSignal spun off, and InnoSign was established as the new entity. InnoSign approached us to develop their new identity, focusing on the pharmaceutical industry while adopting an innovative character.
SOLUTION
We created a contrasted visual identity and website where a clean and clinical tone collides with dense dark green and radiant colors. The visual system represents the 'pathways,' providing a direct and identifiable visualization of their platform. This makes them stand out in the pharmaceutical industry while adapting their ethics with the sole purpose of attracting new innovative partners and investors in key markets.
The visual system represents the 'pathways' from OncoSignal's platform. The spheres project the outcome of a test in a simple yet powerful manner.
This fundamental principle is adapted throughout the entire visual identity and brand marks, creating a connection between the entity and its products.
Read more about our branding approach.
The website serves as a platform for product information and sharing knowledge.
Let's charge your brand into a head turning entity.
Want to know how we can make your brand thrive? Drop us a line. We won't bite (pinky swear).
